Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary series.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• LBVD (Hexavalent Vaccine)

Snippet

Sponsor: LG Chem | Conditions: Diphtheria, Tetanus | Phase 2, Phase 3 | Status: UNKNOWN